By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Astellas Pharma Inc. 

3-11 Nihonbashi-Honcho 2-chome

Chuo-ku  Tokyo  103-8411  Japan
Phone: 81-3-3244-3000 Fax: 81-3-3244-3272





Gilead (Durham, NC) 

Company News
Astellas Pharma Inc. (ALPMY) And Medivation, Inc. (MDVN) Announce New Enzalutamide Data Presented At The 2015 American Urological Association Annual Meeting 5/18/2015 8:11:15 AM
Astellas Pharma Inc. (ALPMY) Announces New Data In Advanced Prostate And Breast Cancers, Acute Myeloid Leukemia, And Lung And Renal Cancers To Be Presented At 2015 ASCO Annual Meeting 5/14/2015 6:48:27 AM
Cyclenium Pharma Announces Drug Discovery Collaboration Agreement With Astellas Pharma Inc. (ALPMY) 5/12/2015 9:41:49 AM
Astellas Pharma Inc. (ALPMY) Announces New Data To Be Presented During Late Breaking Plenary Session At AUA Annual Meeting 5/5/2015 10:23:05 AM
Astellas Pharma Inc. (ALPMY) Launches CRESEMBA (isavuconazonium sulfate) In The United States For The Treatment Of Invasive Aspergillosis And Invasive Mucormycosis 4/27/2015 8:13:03 AM
Astellas Pharma Inc. (ALPMY) And Potenza Therapeutics Partner To Build A Portfolio Of Immuno-Oncology Therapeutics 4/22/2015 11:14:38 AM
Jennifer Saputo Joins Astellas Pharma Inc. (ALPMY) Corporate Affairs 4/15/2015 10:39:00 AM
Ventana Medical Systems, Inc. (VMSI) And Astellas Pharma Inc. (ALPMY) Join Forces To Leverage Novel Companion Diagnostic Tests For Targeted Cancer Treatments 4/14/2015 9:16:33 AM
Astellas Pharma Inc. (ALPMY) Appoints Shontelle Dodson To Lead Medical Excellence Function 4/6/2015 10:17:24 AM
MD Anderson Cancer Center, Astellas Pharma Inc. (ALPMY) Sign Option Agreement For Monoclonal Antibody Drug Targeting Acute Myeloid Leukemia 4/3/2015 7:13:13 AM